Azole derivatives as Wtn pathway inhibitors

Details for Australian Patent Application No. 2010255552 (hide)

Owner Oslo University Hospital HF

Inventors Holsworth, Dan; Waaler, Jo; Machon, Ondrej; Krauss, Stefan

Agent Davies Collison Cave

Pub. Number AU-A-2010255552

PCT Pub. Number WO2010/139966

Priority 09251497.5 05.06.09 EP

Filing date 7 June 2010

Wipo publication date 9 December 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 35/00 (2006.01) Antineoplastic agents

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/139966 Priority application(s): WO2010/139966

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010255559-Method and apparatus for producing at least one argon-enriched fluid and at least one oxygen-enriched fluid from a residual fluid

2010255551-Device and method for determining the composition of a mixture of fluids